Blood test to guide blood thinner use in cancer
Part of Heart & circulation clinical trials.
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You had a blood clot in your leg or lung because of your cancer
- You have been on a blood thinner for 3 to 12 months and are still taking it
- You have one of these cancers: breast, liver/bile duct, prostate, non-small cell lung, pancreatic, or bladder
- Your cancer is advanced (cannot be removed by surgery) or you are getting cancer treatment within the last month or two
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This study looks for “biomarkers,” or blood signs, that may help detect hidden (occult) cancer in people who recently had a blood clot in the leg or a lung clot. It may help doctors catch cancer earlier by improving detection after venous thromboembolism.
This trial tests whether continuing a lower dose of blood thinners can prevent another blood clot in cancer patients who have had a clot in an arm or chest catheter. It may help find a safer way to prevent future clots.
This study compares two blood-thinning medications, edoxaban and apixaban, in people who have both cancer and a blood clot. The goal is to see which one works better and is safer for preventing another clot while treating your cancer.
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
This trial tests a new anticoagulant medication to treat and prevent blood clots in patients with active cancer. You may qualify if you have a recent clot in your leg or lungs and are already taking a blood thinner.
Hear when a new Venous Thromboembolism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.